miRNA General Information
miRNA Mature ID hsa-miR-186-5p
miRNA Stemloop AC MI0000483
miRNA Stemloop ID hsa-mir-186
Sequence caaagaauucuccuuuugggcu
TTD Target(s) Regulated by This miRNA Multidrug resistance protein 1 (ABCB1) Clinical trial Target Target Info [1]
Fibroblast growth factor-2 (FGF2) Successful Target Target Info [2]
Vascular endothelial growth factor A (VEGFA) Successful Target Target Info [3]
Casein kinase II alpha (CSNK2A1) Clinical trial Target Target Info [4]
MAPK/ERK kinase kinase 2 (MAP3K2) Clinical trial Target Target Info [5]
P2X purinoceptor 7 (P2RX7) Clinical trial Target Target Info [6]
X-linked inhibitor of apoptosis protein (XIAP) Clinical trial Target Target Info [7]
Gap junction alpha-1 protein (GJA1) Clinical trial Target Target Info [8]
Hypoxia-inducible factor 1 alpha (HIF-1A) Clinical trial Target Target Info [9]
Lysine N-methyltransferase 3A (SETD2) Literature-reported Target Target Info [9]
Forkhead box protein O1A (FOXO1) Literature-reported Target Target Info [10]
Protein(s) Regulated by This miRNA A-kinase anchor protein 12 Regulated Protein [11]
Nicastrin Regulated Protein [12]
Protein phosphatase 1B Regulated Protein [13]
Securin Regulated Protein [14]
Serine/threonine-protein kinase PAK 6 Regulated Protein [7]
Telomeric repeat-binding factor 2-interacting protein 1 Regulated Protein [16]
Twist-related protein 1 Regulated Protein [17]
References
REF 1 MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1. J Ovarian Res. 2015 Dec 2;8:80.
REF 2 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010 Apr 2;141(1):129-41.
REF 3 Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer. Oncotarget. 2016 Jul 12;7(28):44350-44364.
REF 4 MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):173-9.
REF 5 MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer. Int J Oncol. 2016 Oct;49(4):1437-44.
REF 6 MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem. 2008 Oct 17;283(42):28274-86.
REF 7 CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget. 2015 Sep 22;6(28):25339-55.
REF 8 Identification of miR-200a as a novel suppressor of connexin 43 in breast cancer cells. Biosci Rep. 2015 Aug 17;35(5). pii: e00251.
REF 9 MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1 regulation. Oncogenesis. 2016 May 9;5:e224.
REF 10 Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009 Aug 28;284(35):23204-16.
REF 11 Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.Hepatology. 2010 Dec;52(6):2023-33.
REF 12 MicroRNAs targeting Nicastrin regulate A production and are affected by target site polymorphisms.Front Mol Neurosci. 2014 Jul 18;7:67.
REF 13 miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.Tumour Biol. 2016 Apr;37(4):4331-41.
REF 14 PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186.Carcinogenesis. 2013 Sep;34(9):2145-55.
REF 15 CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget. 2015 Sep 22;6(28):25339-55.
REF 16 Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells.PLoS One. 2014 Apr 21;9(4):e92088.
REF 17 miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.Oncotarget. 2016 Nov 29;7(48):79956-79963.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.